Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method
Viruses · 30.03.2023 · 15 (4) · 891
DOI: 10.3390/v15040891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 30.03.2023. Verfasst von Huijun Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cechanover Institute of Precision and Regenerative Medicine, School of Medicine, The Chinese University of Hong Kong (Shenzhen), Shenzhen 518172, Chi…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ganghong Young Scholar Development Fund and fund from Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation.
Abstract (Originalsprache)
The COVID-19 pandemic caused by SARS-CoV-2 remains a global public health threat and has prompted the development of antiviral therapies. Artificial intelligence may be one of the strategies to facilitate drug development for emerging and re-emerging diseases. The main protease (Mpro) of SARS-CoV-2 is an attractive drug target due to its essential role in the virus life cycle and high conservation among SARS-CoVs. In this study, we used a data augmentation method to boost transfer learning model performance in screening for potential inhibitors of SARS-CoV-2 Mpro. This method appeared to outperform graph convolution neural network, random forest and Chemprop on an external test set. The fine-tuned model was used to screen for a natural compound library and a de novo generated compound library. By combination with other in silico analysis methods, a total of 27 compounds were selected for experimental validation of anti-Mpro activities. Among all the selected hits, two compounds (gyssypol acetic acid and hyperoside) displayed inhibitory effects against Mpro with IC50 values of 67.6 μM and 235.8 μM, respectively. The results obtained in this study may suggest an effective strategy of discovering potential therapeutic leads for SARS-CoV-2 and other coronaviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cechanover Institute of Precision and Regenerative Medicine, School of Medicine, The Chinese University of Hong Kong (Shenzhen), Shenzhen 518172, China.
- School of Life Sciences, University of Science and Technology of China, Hefei 230026, China.
- Nobel Institute of Biomedicine, Zhuhai 519080, China.
- Division of Infectious Diseases and Global Public Health, Department of Medicine, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
- School of Life Sciences, Tsinghua University, Beijing 100084, China.
Förderung
- Ganghong Young Scholar Development Fund and fund from Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation
Zitieren
APA
Zhang, H., Liang, B., Sang, X., An, J., & Huang, Z. (2023). Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method. Viruses, 15(4), 891. https://doi.org/10.3390/v15040891
Vancouver
Zhang H, Liang B, Sang X, An J, Huang Z. Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method. Viruses. 2023;15(4):891. doi:10.3390/v15040891
BibTeX
@article{Zhang2023,
author = {Zhang, Huijun and Liang, Boqiang and Sang, Xiaohong and An, Jing and Huang, Ziwei},
title = {Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method},
journal = {Viruses},
year = {2023},
volume = {15},
number = {4},
pages = {891},
doi = {10.3390/v15040891}
}
EUVIMED